MetaCure Announces Closing of New Financing Allowing Acceleration of Commercial and Product Development Efforts

ORANGEBURG, N.Y., April 20, 2009 (GLOBE NEWSWIRE) -- MetaCure announced today that it has recently closed a new round of financing of $20 million from institutional and private investors that will provide the necessary capital for realizing its strategic plans. This transaction is part of a US$124.5 million facility that was provided to a portfolio of affiliated companies. Sarit Molcho and Amir Shavitzky of the Tel-Aviv law firm of S. Friedman & Co., represented the companies in the transaction.

Back to news